CT coronary angiography, myocardial perfusion imaging, magnetic resonance angiography, molecular imaging in cardiovascular disease.
Williams, M. C., Hunter, A., Shah, A. S. V., Dreisbach, J., Weir-McCall, J. R., Macmillan, M. T., et al. (2018). Impact of noncardiac findings in patients undergoing CT coronary angiography: a substudy of the Scottish computed tomography of the heart (SCOT-HEART) trial. European Radiology, 70, ii1–8.
Williams MC, Hunter A, Shah A, et al. Symptoms and quality of life in patients with suspected angina undergoing CT coronary angiography: a randomised controlled trial. Heart 2017
Williams MC, Mirsadraee S, Dweck MR, et al. Computed tomography myocardial perfusion vs 15O-water positron emission tomography and fractional flow reserve. European Radiology 2016.
Williams MC, et al.Impact of Coronary Computed Tomography Angiography on Clinical Management and Outcomes in Patients with Suspected Angina due to Coronary Heart Disease. Journal of the American College of Cardiology, 2016; 67(15): 1759-1768.
Williams MC, Golay SK, Hunter A, et al. Observer variability in the assessment of CT coronary angiography and coronary artery calcium score: sub-study of the Scottish Computed Tomography of the HEART (SCOT-HEART) trial. Open Heart, 2015: 2; e000234.
SCOT-HEART Trialists, Newby DE, Williams MC, et al. CT coronary angiography in patients with suspected angina due to coronary heart disease (SCOT-HEART): an open-label, parallel-group, multicentre trial. Lancet, 2015: 385(9985); 2383–2391.
Williams MC, Murchison JT, Edwards LD, et al. Coronary artery calcification is increased in patients with